Efficacy and safety evaluations of anlotinib in patients with advanced non-small cell lung cancer treated with bevacizumab

Objective: The purpose of this study is to evaluate the efficacy and safety of anlotinib in patients with advanced non-small cell lung cancer (NSCLC) who had previously received bevacizumab. Methods: The participants were histopathologically or cytologically diagnosed advanced NSCLC patients whose d...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Fenge, Li, Junxia, Kong, Xiangshuo, Sun, Ping, Qu, Huajun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552664/
https://www.ncbi.nlm.nih.gov/pubmed/36238567
http://dx.doi.org/10.3389/fphar.2022.973448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552664/
https://www.ncbi.nlm.nih.gov/pubmed/36238567
http://dx.doi.org/10.3389/fphar.2022.973448

Ejemplares similares